Upcoming Webinars

Transforming Pediatric Rare Disease Trials Through Modeling and Simulation, and Site Networks

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • February 18, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Accelerating Clinical Entry for Poorly Soluble Molecules: A Proven and Structured Roadmap

Biotech, Drug Discovery & Development, Life Science, Pharma, Preclinical,
  • February 19, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

How Community-Based Trials Are Delivering Results: Investigator and Site Perspectives

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • February 19, 2026 | 12pm EST (11am CST / 9am PST / 5pm GMT)
  • 60 min

Upcoming Webinars

Site Selection Solutions Using Patient Insights for Rare Disease Trials

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • February 20, 2026 | 10am EST (NA) / 3pm GMT (UK) / 4pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 1)

Biotech, Cell and Gene Therapy, Drug Discovery & Development, Laboratory Technology, Life Science, Pharma, Pharma Manufacturing & Supply Chain,
  • February 24, 2026 | 8am GMT (UK) / 9am CET (EU-Central) / 4pm CST (China) / 5pm JST (Japan) / 5pm KST (Korea)
  • 60 min

Upcoming Webinars

February 18, 2026

Transforming Pediatric Rare Disease Trials Through Modeling and Simulation, and Site Networks
February 19, 2026

Accelerating Clinical Entry for Poorly Soluble Molecules: A Proven and Structured Roadmap
February 19, 2026

How Community-Based Trials Are Delivering Results: Investigator and Site Perspectives
EmVenio Hero
February 20, 2026

Site Selection Solutions Using Patient Insights for Rare Disease Trials
February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 1)
February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 2)
February 24, 2026

Addressing Rising LQPPV and Lifecycle Management Demands Using Applied AI
Hero-Banner-1600
February 24, 2026

How Moderna Uses Decision Intelligence to Enable an Autonomous Cold Chain
February 25, 2026

Maximizing Value in Early-Phase Oncology Trials: Innovative Endpoints for Early Insights
February 25, 2026

From FIH to POC — Designing Phase I/Ib Trials with Efficiency
February 26, 2026

Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know
February 26, 2026

Engaging Community Voices to Improve Clinical Trial Access
February 26, 2026

How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics
February 27, 2026

Peptide Synthesis: New Sustainable Strategies for Regulatory and Market Demands
February 27, 2026

3 Key Trends Transforming the Future of Rare Disease Clinical Development
February 27, 2026

Enhancing Life Sciences Supply Chain Resilience with Unified Platforms